Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Huband · SciRah

Researcher profile · Semantic Scholar

M. Huband

Share profile

M. Huband — researcher profile on SciRah

h-index: 37
Works: 163
Citations: 4,084

Most-cited papers

Meropenem-Vaborbactam Tested against Contemporary Gram-Negative Isolates Collected Worldwide during 2014, Including Carbapenem-Resistant, KPC-Producing, Multidrug-Resistant, and Extensively Drug-Resistant Enterobacteriaceae
M. Castanheira, M. Huband, R. Mendes, R. Flamm
2017Antimicrobial Agents and Chemotherapy157 citations Open access
Semantic Scholar
Geographic and Temporal Patterns of Antimicrobial Resistance in Pseudomonas aeruginosa Over 20 Years From the SENTRY Antimicrobial Surveillance Program, 1997–2016
D. Shortridge, A. Gales, J. Streit, M. Huband +2 more
2019Open Forum Infectious Diseases127 citations Open access
Semantic Scholar
Pseudomonas aeruginosa Antimicrobial Susceptibility Results from Four Years (2012 to 2015) of the International Network for Optimal Resistance Monitoring Program in the United States
H. Sader, M. Huband, M. Castanheira, R. Flamm
2017Antimicrobial Agents and Chemotherapy111 citations Open access
Semantic Scholar
In vitro activity of meropenem/vaborbactam and characterisation of carbapenem resistance mechanisms among carbapenem-resistant Enterobacteriaceae from the 2015 meropenem/vaborbactam surveillance programme.
M. Pfaller, M. Huband, R. Mendes, R. Flamm +1 more
2018International Journal of Antimicrobial Agents87 citations
Semantic Scholar
WCK 5222 (Cefepime-Zidebactam) Antimicrobial Activity against Clinical Isolates of Gram-Negative Bacteria Collected Worldwide in 2015
H. Sader, M. Castanheira, M. Huband, Ronald N. Jones +1 more
2017Antimicrobial Agents and Chemotherapy74 citations Open access
Semantic Scholar
In Vitro Activity of APX001A (Manogepix) and Comparator Agents against 1,706 Fungal Isolates Collected during an International Surveillance Program in 2017
M. Pfaller, M. Huband, R. Flamm, Paul A. Bien +1 more
2019Antimicrobial Agents and Chemotherapy73 citations Open access
Semantic Scholar
Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe as Part of the 2016 SENTRY Antimicrobial Surveillance Program
M. Pfaller, M. Huband, D. Shortridge, R. Flamm
2018Antimicrobial Agents and Chemotherapy62 citations Open access
Semantic Scholar
Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe: Report from the SENTRY Antimicrobial Surveillance Program, 2016 to 2018
M. Pfaller, M. Huband, D. Shortridge, R. Flamm
2020Antimicrobial Agents and Chemotherapy53 citations Open access
Semantic Scholar
Surveillance of Omadacycline Activity against Clinical Isolates from a Global Collection (North America, Europe, Latin America, Asia-Western Pacific), 2010-2011
M. Pfaller, M. Huband, P. Rhomberg, R. Flamm
2017Antimicrobial Agents and Chemotherapy51 citations Open access
Semantic Scholar
Antimicrobial Activity of First-in-Class Antifungal, Manogepix, and Comparator Agents Testing against Contemporary Invasive Fungal Isolates from an International Surveillance Program (2018-2019): In Vitro Activity of Manogepix against Fungal Isolates.
M. Pfaller, M. Huband, R. Flamm, Paul A. Bien +1 more
2021Journal of Global Antimicrobial Resistance49 citations Open access
Semantic Scholar
Surveillance of tigecycline activity tested against clinical isolates from a global (North America, Europe, Latin America and Asia-Pacific) collection (2016).
M. Pfaller, M. Huband, J. Streit, R. Flamm +1 more
2018International Journal of Antimicrobial Agents43 citations
Semantic Scholar
In Vitro Activity of Delafloxacin Tested against Isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
R. Flamm, P. Rhomberg, M. Huband, D. Farrell
2016Antimicrobial Agents and Chemotherapy41 citations Open access
Semantic Scholar
Surveillance of omadacycline activity tested against clinical isolates from the United States and Europe: Results from the SENTRY Antimicrobial Surveillance Programme, 2017.
M. Huband, M. Pfaller, D. Shortridge, R. Flamm
2019Journal of Global Antimicrobial Resistance39 citations
Semantic Scholar
Cefiderocol MIC quality control ranges in iron-depleted cation-adjusted Mueller-Hinton broth using a CLSI M23-A4 multi-laboratory study design.
M. Huband, Akinobu Ito, M. Tsuji, H. Sader +2 more
2017Diagnostic microbiology and infectious disease35 citations
Semantic Scholar
Activities of Omadacycline and Comparator Agents against Staphylococcus aureus Isolates from a Surveillance Program Conducted in North America and Europe
M. Pfaller, P. Rhomberg, M. Huband, R. Flamm
2016Antimicrobial Agents and Chemotherapy35 citations Open access
Semantic Scholar
Novel 3-fluoro-6-methoxyquinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV.
M. Mitton-Fry, S. J. Brickner, J. C. Hamel, R. Barham +21 more
2017Bioorganic & Medicinal Chemistry Letters33 citations Open access
Semantic Scholar
Activities of Manogepix and Comparators against 1,435 Recent Fungal Isolates Collected during an International Surveillance Program (2020)
M. Pfaller, M. Huband, P. Rhomberg, Paul A. Bien +1 more
2022Antimicrobial Agents and Chemotherapy32 citations Open access
Semantic Scholar
Frequency of occurrence and antimicrobial susceptibility of bacteria isolated from respiratory samples of patients hospitalized with pneumonia in Western Europe, Eastern Europe and the USA: results from the SENTRY Antimicrobial Surveillance Program (2016–19)
H. Sader, J. Streit, C. Carvalhaes, M. Huband +3 more
2021JAC-Antimicrobial Resistance29 citations Open access
Semantic Scholar
Activity of omadacycline tested against Streptococcus pneumoniae from a global surveillance program (2014).
M. Pfaller, P. Rhomberg, M. Huband, R. Flamm
2018Diagnostic microbiology and infectious disease29 citations
Semantic Scholar
Surveillance of omadacycline activity tested against clinical isolates from the United States: Report from the SENTRY Antimicrobial Surveillance Program, 2019: Omadacycline 2019 Surveillance - USA.
M. Pfaller, M. Huband, D. Shortridge, R. Flamm
2021Journal of Global Antimicrobial Resistance26 citations Open access
Semantic Scholar
In Vitro Activity of KBP-7072, a Novel Third-Generation Tetracycline, against 531 Recent Geographically Diverse and Molecularly Characterized Acinetobacter baumannii Species Complex Isolates
M. Huband, R. Mendes, M. Pfaller, Jill M. Lindley +8 more
2020Antimicrobial Agents and Chemotherapy26 citations Open access
Semantic Scholar
Antimicrobial Activity of Omadacycline Tested against Clinical Bacterial Isolates from Hospitals in Mainland China, Hong Kong, and Taiwan: Results from the SENTRY Antimicrobial Surveillance Program (2013 to 2016)
C. Carvalhaes, M. Huband, H. Reinhart, R. Flamm +1 more
2019Antimicrobial Agents and Chemotherapy26 citations Open access
Semantic Scholar
In vitro activity of manogepix and comparators against infrequently encountered yeast and mold isolates from the SENTRY Surveillance Program (2017–2022)
M. Pfaller, M. Huband, Paul A. Bien, C. Carvalhaes +2 more
2024Antimicrobial Agents and Chemotherapy25 citations Open access
Semantic Scholar
BWC0977, a broad-spectrum antibacterial clinical candidate to treat multidrug resistant infections
S. Hameed P., H. Kotakonda, Sreevalli Sharma, Radha Nandishaiah +45 more
2024Nature Communications22 citations Open access
Semantic Scholar
Activity of omadacycline tested against Enterobacteriaceae causing urinary tract infections from a global surveillance program (2014).
M. Pfaller, P. Rhomberg, M. Huband, R. Flamm
2018Diagnostic microbiology and infectious disease20 citations
Semantic Scholar
Ceftazidime–Avibactam Antimicrobial Activity and Spectrum When Tested Against Gram-negative Organisms From Pediatric Patients: Results From the INFORM Surveillance Program (United States, 2011–2015)
H. Sader, M. Huband, Leonard R. Duncan, R. Flamm
2017The Pediatric Infectious Disease Journal20 citations
Semantic Scholar
Elderly versus nonelderly patients with invasive fungal infections: species distribution and antifungal resistance, SENTRY antifungal surveillance program 2017-2019.
M. Pfaller, C. Carvalhaes, Sean DeVries, M. Huband +1 more
2021Diagnostic microbiology and infectious disease19 citations Open access
Semantic Scholar
Frequency and antimicrobial susceptibility of bacterial isolates from patients hospitalised with community-acquired skin and skin-structure infection in Europe, Asia and Latin America.
H. Sader, J. Streit, C. Carvalhaes, M. Huband +1 more
2019Journal of Global Antimicrobial Resistance19 citations
Semantic Scholar
Development of Broth Microdilution MIC and Disk Diffusion Antimicrobial Susceptibility Test Quality Control Ranges for the Combination of Cefepime and the Novel β-Lactamase Inhibitor Enmetazobactam
A. Belley, M. Huband, Kelley A. Fedler, Amy A. Watters +3 more
2019Journal of Clinical Microbiology17 citations Open access
Semantic Scholar
Ceftazidime-Avibactam Activity against Aerobic Gram Negative Organisms Isolated from Intra-Abdominal Infections in United States Hospitals, 2012–2014
H. Sader, M. Castanheira, R. Flamm, M. Huband +1 more
2016Surgical Infections17 citations
Semantic Scholar
Antimicrobial activity of dalbavancin against Gram-positive bacteria isolated from patients hospitalized with bloodstream infection in United States and European medical centers (2018–2020)
H. Sader, M. Castanheira, M. Huband, D. Shortridge +2 more
2022European Journal of Clinical Microbiology and Infectious Diseases16 citations Open access
Semantic Scholar
A Systematic Approach to the Selection of the Appropriate Avibactam Concentration for Use with Ceftazidime in Broth Microdilution Susceptibility Testing
P. Bradford, M. Huband, G. Stone
2018Antimicrobial Agents and Chemotherapy16 citations Open access
Semantic Scholar
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses Evaluating Omadacycline Dosing Regimens for the Treatment of Patients with Community-Acquired Bacterial Pneumonia Arising from Streptococcus pneumoniae and Haemophilus influenzae
S. Bhavnani, J. Hammel, E. Lakota, M. Trang +8 more
2023Antimicrobial Agents and Chemotherapy13 citations Open access
Semantic Scholar
In vitro activity of sulopenem and comparator agents against Enterobacterales and anaerobic clinical isolates collected during the SENTRY Antimicrobial Surveillance Program
Joshua M. Maher, M. Huband, Christopher G Blankers, S. Puttagunta +2 more
2023Journal of Antimicrobial Chemotherapy12 citations Open access
Semantic Scholar
Characterization of sulopenem antimicrobial activity using in vitro time-kill kinetics, synergy, post-antibiotic effect, and sub-inhibitory MIC effect methods against Escherichia coli and Klebsiella pneumoniae isolates
Joshua M. Maher, M. Huband, Jill M. Lindley, P. Rhomberg +3 more
2025Microbiology spectrum11 citations Open access
Semantic Scholar
Antimicrobial activity of ceftibuten-avibactam against a global collection of Enterobacterales from patients with urinary tract infections (2021)
H. Sader, C. Carvalhaes, M. Huband, R. Mendes +1 more
2023European Journal of Clinical Microbiology and Infectious Diseases11 citations Open access
Semantic Scholar
Antimicrobial Activity of Telavancin Tested In Vitro Against a Global Collection of Gram-Positive Pathogens, Including Multidrug-Resistant Isolates (2015–2017)
Leonard R. Duncan, H. Sader, M. Huband, R. Flamm +1 more
2020Microbial Drug Resistance11 citations
Semantic Scholar
Assessment of 30/20-Microgram Disk Content versus MIC Results for Ceftazidime-Avibactam Tested against Enterobacteriaceae and Pseudomonas aeruginosa
H. Sader, P. Rhomberg, M. Huband, I. Critchley +3 more
2018Journal of Clinical Microbiology11 citations Open access
Semantic Scholar
Antifungal Activity of Isavuconazole and Comparator Agents against Contemporaneous Mucorales Isolates from USA, Europe, and Asia-Pacific
C. Carvalhaes, P. Rhomberg, M. Huband, M. Pfaller +1 more
2023Journal of Fungi10 citations Open access
Semantic Scholar
Determination of MIC Quality Control Ranges for the Novel Gyrase Inhibitor Zoliflodacin
Alita A. Miller, M. Traczewski, M. Huband, P. Bradford +1 more
2019Journal of Clinical Microbiology10 citations Open access
Semantic Scholar
Determination of MIC and disk diffusion quality control guidelines for meropenem-vaborbactam, a novel carbapenem/boronic acid β-lactamase inhibitor combination.
Erik Munson, M. Huband, M. Castanheira, Kelley A. Fedler +1 more
2017Diagnostic microbiology and infectious disease10 citations
Semantic Scholar
Sulbactam-durlobactam susceptibility test method development and quality control ranges for MIC and disk diffusion tests
Sarah M. McLeod, Nicole M. Carter, M. Huband, M. Traczewski +2 more
2023Journal of Clinical Microbiology9 citations Open access
Semantic Scholar
Activity of the Novel Aminomethylcycline KBP-7072 and Comparators against 1,057 Geographically Diverse Recent Clinical Isolates from the SENTRY Surveillance Program, 2019
M. Huband, Jennifer D. Thompson, N. Gurung, Qingmei Liu +4 more
2021Antimicrobial Agents and Chemotherapy9 citations Open access
Semantic Scholar
Omadacycline invitro activity against a molecularly characterized collection of clinical isolates with known acquired tetracycline resistance mechanisms.
R. Mendes, M. Huband, J. Streit, M. Castanheira +1 more
2020Diagnostic microbiology and infectious disease9 citations
Semantic Scholar
1363. Sulopenem Activity Against Enterobacteriaceae Isolates From Patients With Urinary Tract Infection or Intra-Abdominal Infection
S. Puttagunta, S. Aronin, M. Huband, R. Flamm +1 more
2018Open Forum Infectious Diseases8 citations Open access
Semantic Scholar
High Rates of Nonsusceptibility to Common Oral Antibiotics in Streptococcus pneumoniae Clinical Isolates From the United States (2019–2021)
L. Deshpande, M. Huband, Sarah Charbon, M. Castanheira +1 more
2024Open Forum Infectious Diseases7 citations Open access
Semantic Scholar
Impact of surfactants and other body fluids on in vitro activity of a novel β-lactamase inhibitor enmetazobactam in combination with cefepime against clinical isolates of Klebsiella pneumoniae
A. Nussbaumer-Pröll, Sabine Eberl, A. Belley, Philipp Knechtle +3 more
2023Journal of antibiotics (Tokyo. 1968)7 citations
Semantic Scholar
Effect of Susceptibility Testing Conditions on the In Vitro Antibacterial Activity of ETX0914.
R. Giacobbe, M. Huband, B. DeJonge, P. Bradford
2017Diagnostic microbiology and infectious disease7 citations
Semantic Scholar
Surveillance of omadacycline against 35,000 bacterial clinical isolates from the United States (2019-2023).
M. Huband, Kelley A. Fedler, R. Mendes, H. Sader +3 more
2025Diagnostic microbiology and infectious disease6 citations Open access
Semantic Scholar
Determination of MIC Quality Control Ranges for Ceftibuten-Avibactam (Fixed 4 μg/mL), a Novel β-Lactam/β-Lactamase Inhibitor Combination
M. Huband, Kelley A. Fedler, H. Sader, G. Stone +1 more
2023Journal of Clinical Microbiology6 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Flamm×28
Invite
R. Flamm — researcher profile on SciRah
M. Castanheira×22
Invite
M. Castanheira — researcher profile on SciRah
M. Pfaller×17
Invite
M. Pfaller — researcher profile on SciRah
H. Sader×15
Invite
H. Sader — researcher profile on SciRah

×9

Invite

R. Mendes — researcher profile on SciRah

Invite

P. Rhomberg — researcher profile on SciRah

C. Carvalhaes×8

Invite

C. Carvalhaes — researcher profile on SciRah

D. Shortridge×7

Invite

D. Shortridge — researcher profile on SciRah

Invite

J. Streit — researcher profile on SciRah

Kelley A. Fedler×5

Invite

Kelley A. Fedler — researcher profile on SciRah

Ronald N. Jones×4

Invite

Ronald N. Jones — researcher profile on SciRah

Paul A. Bien×4

Invite

Paul A. Bien — researcher profile on SciRah